Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EWZ vs GSK✓SelectedUSD · GSKEWZ vs GSK performance historyLatest closeAs of-4.03%11/16
Stock and ETF performance explorer

EWZ vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+56.4%
GSK return
+107.3%
Excess return
-50.8%
Maximum drawdown
-57.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.0%-0.1%-4.0%-4.0%
7D-5.2%-1.3%-3.9%-4.7%
30D-26.1%+2.7%-28.8%-27.1%
3M-8.9%+2.7%-11.6%-10.4%
6M-13.8%+3.3%-17.2%-16.0%
YTD-1.7%+6.5%-8.2%-6.2%
1Y-2.6%+10.7%-13.3%-8.7%
3Y+9.4%+64.4%-55.0%-20.1%
5Y+51.5%+46.7%+4.8%+14.7%
10Y+56.4%+109.4%-52.9%-4.2%
All+56.4%+107.3%-50.8%-4.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling